VF Corporation Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

STOCK-BASED COMPENSATION (Tables)

STOCK-BASED COMPENSATION (Tables)

12 Months Ended

Mar. 28, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Total Stock-Based Compensation Cost and Associated Income Tax Benefits

Total stock-based compensation cost and the associated income tax benefits recognized in the Consolidated Statements of Operations, on a continuing operations basis, were as follows:


	Year Ended March

(In thousands)	2026		2025		2024
Stock-based compensation cost	$	76,954	$	73,247	$	57,829
Income tax benefits	17,729		16,299		12,849

Schedule of Assumption Used and Resulting Weighted Average Fair Value of Stock Option Granted

The grant date fair value of each option award was calculated using a lattice option-pricing valuation model, which incorporated a range of assumptions for inputs as follows:

Year Ended March

2026 (a)

2025

2024

Expected volatility

N/A

37% to 53%

33% to 54%

Weighted average expected volatility

N/A

47%

42%

Expected term (in years)

N/A

5.5 to 7.3

5.9 to 7.8

Weighted average dividend yield

N/A

2.2%

3.7%

Risk-free interest rate

N/A

3.80% to 5.43%

3.80% to 5.50%

Weighted average fair value at date of grant

N/A

$5.31

$5.74

(a) Not applicable, as no options were granted during the year ended March 2026.

Schedule of Stock Option Activity

Stock option activity for the year ended March 2026 is summarized as follows:


	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (In thousands)
Outstanding, March 2025	17,080,438	$	32.80
Granted	—	—
Exercised	(536,970)	15.60
Forfeited/cancelled	(3,616,393)	54.38
Outstanding, March 2026	12,927,075	$	27.48	6.8	$	18,772
Exercisable, March 2026	8,288,760	$	34.63	6.2	$	7,619

Schedule of RSU Activity

RSU and stock unit activity for the year ended March 2026 is summarized as follows:


	Performance-based (a)			Nonperformance-based (b)
	Number Outstanding (c)	Weighted Average Grant Date Fair Value		Number Outstanding	Weighted Average Grant Date Fair Value
Outstanding, March 2025	2,401,772	$	19.60	6,011,850	$	18.70
Granted	885,143	6.76		5,967,873	12.74
Issued as Common Stock	—	—		(1,763,562)	20.91
Forfeited/cancelled	(213,153)	45.15		(862,869)	15.56
Outstanding, March 2026	3,073,762	$	14.13	9,353,292	$	14.77
Vested, March 2026	1,079,163	$	17.50	483,422	$	16.49

(a)Includes the portion of RSUs granted to executives in Fiscal 2026 that are subject to TSR targets, described in more detail above.

(b)Includes the portion of RSUs granted to executives in Fiscal 2026 that are not subject to TSR targets, described in more detail above.

(c)Reflects activity at target level of awards and has not been adjusted for performance and market conditions, except for awards issued during the period.

Schedule of Restricted Stock Activity

Restricted stock activity for the year ended March 2026 is summarized below:


	Nonvested Shares Outstanding	Weighted Average Grant Date Fair Value
Nonvested shares, March 2025	11,613	$	71.43
Granted	—	—
Dividend equivalents	—	—
Vested	(11,613)	71.43
Forfeited	—	—
Nonvested shares, March 2026	—	$	—